This stands in contrast to the RIP-LCMV-GP model for fast-onset type 1 diabetes (T1D), in which the entire GP of LCMV is expressed under the control of the rat insulin promoter (RIP) in the β-cells of the islets of Langerhans in the pancreas (25, 26). The gene discussed is INS; the disease is type 1 diabetes mellitus.